Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients

Abadie, 1993, Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation in the obese Zucker rat, Diabetes, 42, 662, 10.2337/diab.42.5.662 Akiva, 1991, Neurosteroids, J Steroid Biochem Mol Biol, 40, 71, 10.1016/0960-0760(91)90169-6 Avery, 1977, The efficacy of electroconvulsive therapy and antidepressants in depression, Biol Psychiatry, 12, 507 Avery, 1993, Electroconvulsive therapy, 524 Barton, 1977, ECT in depression, Biol Psychiatry, 12, 687 Baulieu, 1991, Neurosteroids, Biol Cell, 71, 3, 10.1016/0248-4900(91)90045-O Baulieu, 1992, Neurosteroids, 1 Baulieu, 1997, Neurosteroids, Recent Prog Horm Res, 52, 1 Baulieu, 1990, Neurosteroids, J Steroid Biochem Mol Biol, 37, 305, 10.1016/0960-0760(90)90490-C Baulieu, 1996, Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive steroids, J Endocrinol, 150, S221 Baulieu, 1998, Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) as neuroactive steroids, Proc Natl Acad Sci U S A, 95, 4089, 10.1073/pnas.95.8.4089 Berr, 1996, Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality, Proc Natl Acad Sci U S A, 93, 13410, 10.1073/pnas.93.23.13410 Coffey, 1995, Seizure threshold in electroconvulsive therapy (ECT), Biol Psychiatry, 37, 777, 10.1016/0006-3223(95)00053-J D’Elia, 1970, Unilateral electroconvulsive therapy, Acta Psychiatr Scand Suppl, 215, 5 Demirgoren, 1991, Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor, Neuroscience, 45, 127, 10.1016/0306-4522(91)90109-2 Deslypere, 1983, Seasonal variation of plasma dehydroepiandrosterone sulphate and urinary androgen excretion in post-menopausal women, Clin Endocrinol (Oxf), 18, 25, 10.1111/j.1365-2265.1983.tb03182.x Deutsch, 1992, GABA active steroids, Clin Neuropharmacol, 15, 352, 10.1097/00002826-199210000-00002 Ferguson, 1964, A preliminary investigation of steroid excretion in depressed patients before and after electroconvulsive therapy, Acta Endocrinol (Copenh), 47, 58, 10.1530/acta.0.0470058 Fink, 1992, Electroconvulsive therapy, 359 First MB, Spitzer RL, Gibbon M, Williams JBW (1995): Structural clinical interview for Axis I DSM-IV disorders—patient edition, SCID-T/P, version 2.0. New York: New York State Psychiatric Institute, Biometrics Research Department. Goodyer, 1998, Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression, Psychol Med, 28, 265, 10.1017/S0033291797006314 Guidotti, 1998, Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α,5α-etrahydroprogesterone (allopregnanolone) availability?, Biol Psychiatry, 44, 865, 10.1016/S0006-3223(98)00070-5 Hamilton, 1959, The assessment of anxiety states by rating, Br J Med Psychol, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Hansen, 1982, Dehydroepiandrosterone and affective disorders, Am J Psychiatry, 139, 386, 10.1176/ajp.139.3.386a Haug, 1988, The role of dehydroepiandrosterone and pregnenolone in the expression of stress behavior towards lactating females in mice, Pathol Biol (Paris), 36, 995 Hechter, 1997, Relationship of dehydroepiandrosterone and cortisol in disease, Med Hypotheses, 49, 85, 10.1016/S0306-9877(97)90258-9 Heinz, 1999, Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations, Psychiatry Res, 89, 97, 10.1016/S0165-1781(99)00099-2 Herbert, 1998, Neurosteroids, brain damage, and mental illness, Exp Gerontol, 33, 713, 10.1016/S0531-5565(98)00039-4 Howard, 1992, Severe psychosis and the adrenal androgens, Integr Physiol Behav Sci, 27, 209, 10.1007/BF02690893 Lambourn, 1978, A controlled comparison of simulated and real ECT, Br J Psychiatry, 133, 514, 10.1192/bjp.133.6.514 Majewska, 1992, Neurosteroids, Prog Neurobiol, 38, 379, 10.1016/0301-0082(92)90025-A Majewska, 1995, Neuronal actions of dehydroepiandrosterone. Possible roles in the brain development, aging, memory and affect, Ann N Y Acad Sci, 774, 111, 10.1111/j.1749-6632.1995.tb17375.x Majewska, 1990, The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor, Brain Res, 526, 143, 10.1016/0006-8993(90)90261-9 Majewska, 1986, Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor, Science, 232, 1004, 10.1126/science.2422758 Majewska, 1987, Pregnenolone-sulfate, Brain Res, 404, 355, 10.1016/0006-8993(87)91394-1 Maurice, 1997, Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1 receptors, Behav Brain Res, 83, 159, 10.1016/S0166-4328(97)86061-5 McEwen, 1991, Nongenomic and genomic effects of steroids on neural activity, Trends Pharmacol Sci, 12, 141, 10.1016/0165-6147(91)90531-V Melchior, 1994, Dehydroepiandrosterone is an anxiolytic in mice on the plus maze, Pharmacol Biochem Behav, 47, 437, 10.1016/0091-3057(94)90140-6 Mellon, 1994, Neurosteroid biochemistry, J Clin Endocrinol Metab, 78, 1003 Meltzer, 1990, Defining treatment refractoriness in schizophrenia, Schizophr Bull, 16, 563, 10.1093/schbul/16.4.563 Osran, 1993, Adrenal androgens and cortisol in major depression, Am J Psychiatry, 150, 806, 10.1176/ajp.150.5.806 Overall, 1962, The Brief Psychiatric Rating Scale, Psychol Rep, 10, 799, 10.2466/pr0.1962.10.3.799 Paul, 1992, Neuroactive steroids, FASEB J, 6, 2311, 10.1096/fasebj.6.6.1347506 Prince, 1992, 5β-Pregnan-3β-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor complex, Neurosci Lett, 135, 273, 10.1016/0304-3940(92)90454-F Prudic, 1996, Resistance to antidepressant medications and short-term clinical response to ECT, Am J Psychiatry, 153, 985, 10.1176/ajp.153.8.985 Purdy, 1991, Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain, Proc Natl Acad SciU S A, 8, 4553, 10.1073/pnas.88.10.4553 Reddy, 1998, Sigma (sigma1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test, Neuroreport, 9, 3069, 10.1097/00001756-199809140-00028 Reddy, 1997, Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice, Brain Res, 752, 61, 10.1016/S0006-8993(96)01447-3 Regelson, 1994, Dehydroepiandrosterone (DHEA)—the multifunctional steroid, Ann N Y Acad Sci, 719, 564, 10.1111/j.1749-6632.1994.tb56860.x Reus, 1997, Antiglucocorticosteroid treatments in psychiatry, Psychoneuroendocrinology, 22, S121, 10.1016/S0306-4530(97)00016-4 Robel, 1995, Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid, Ann N Y Acad Sci, 774, 82, 10.1111/j.1749-6632.1995.tb17374.x Robel, 1995, Neurosteroids, Crit Rev Neurobiol, 9, 383 Robel, 1995, Biosynthesis and assay of neurosteroids in rats and mice, J Steroid Biochem Mol Biol, 53, 355, 10.1016/0960-0760(95)00074-A Romeo, 1998, Effects of antidepressant treatment on neuroactive steroids in major depression, Am J Psychiatry, 155, 910, 10.1176/ajp.155.7.910 Sackheim, 1987, Seizure threshold in electroconvulsive therapy, Arch Gen Psychiatry, 44, 355, 10.1001/archpsyc.1987.01800160067009 Sands, 1954, Further studies on endocrine treatment in adolescence and early adult life, J Ment Sci, 100, 211, 10.1192/bjp.100.418.211 Siris, 1995, Depression and schizophrenia, 128 Skolnick, 1996, Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment, Pharmacopsychiatry, 29, 23, 10.1055/s-2007-979537 Solan, 1988, Psychotic and nonpsychotic depression, J Clin Psychiatry, 49, L97 Spivak, 1994, Desensitisation and noncompetitive blockade of GABAA receptors in central midbrain neurons by a neurosteroid dehydroepiandrosterone sulfate, Synapse, 16, 113, 10.1002/syn.890160205 Tollefson, 1990, 24-hour urinary dehydroepiandrosterone sulfate in unipolar depressive treatment with cognitive and/or pharmacotherapy, Ann Clin Psychiatry, 2, 39, 10.3109/10401239009150005 Uzunov, 1996, Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography, Proc Natl Acad SciU S A, 93, 12599, 10.1073/pnas.93.22.12599 Uzunova, 1998, Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine, Proc Natl Acad Sci U S A, 95, 3239, 10.1073/pnas.95.6.3239 Weizman, 1987, The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients, Psychopharmacology, 93, 122, 10.1007/BF02439598 Wolf, 1997, A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels, Biol Psychiatry, 42, 845, 10.1016/S0006-3223(97)00323-5 Wolkowitz, 1997, Gluctocorticoid medication, memory and steroid psychosis in medical illness, Ann N Y Acad Sci, 823, 81, 10.1111/j.1749-6632.1997.tb48381.x Wolkowitz, 1999, Double-blind treatment of major depression with dehydroepiandrosterone, Am J Psychiatry, 156, 646, 10.1176/ajp.156.4.646 Wolkowitz, 1995, Antidepressant and cognition-enhancing effects of DHEA in major depression. Dehydroepiandrosterone and aging, Ann N Y Acad Sci, 774, 337, 10.1111/j.1749-6632.1995.tb17403.x-i1 Wolkowitz, 1997, Dehydroepiandrosterone (DHEA) treatment of depression, Biol Psychiatry, 41, 311, 10.1016/S0006-3223(96)00043-1 Young, 1996, Neurosteroids in the mouse brain, Steroids, 61, 144, 10.1016/0039-128X(95)00220-K Zinder, 1999, Neuroactive steroids, Acta Physiol Scand, 167, 181, 10.1046/j.1365-201x.1999.00579.x